Position in NTRA
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$4,487,068
+$1,181,234 QoQ
Shares Held
16,530
0.0% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#277
of 844 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 57%
Shared 0%
None 43%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026SALEM INVESTMENT COUNSELORS INC holds $21,349,813 across 15 Diagnostics & Research names. NTRA ranks #2 (21.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
17,376 | $8,711,631 | |
| 2 | NTRA |
Natera, Inc.
This page
|
16,530 | $4,487,068 | |
| 3 | MTD |
Mettler Toledo International Inc/
|
3,300 | $4,215,783 | |
| 4 | LH |
Labcorp Holdings Inc.
|
9,605 | $2,689,400 | |
| 5 | MEDP |
Medpace Holdings, Inc.
|
745 | $394,544 | |
| 6 | A |
Agilent Technologies, Inc.
|
2,131 | $283,060 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
1,197 | $231,284 | |
| 8 | DGX |
Quest Diagnostics Inc
|
815 | $172,739 |
All Filings in NTRA
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,487,068 | 16,530 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $3,305,834 | 16,530 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $3,729,585 | 16,280 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $2,620,591 | 16,280 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $2,750,343 | 16,280 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $2,302,154 | 16,280 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $2,577,124 | 16,280 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $2,052,781 | 16,170 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $1,678,495 | 15,500 | Shares | Sole | 2024-07-11 | |
| No filing history on record for this holder in this stock. | ||||||